Hengehold Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.1M Buy
47,453
+1,590
+3% +$186K 0.47% 45
2026
Q1
$5.52M Sell
45,863
-291
-0.6% -$33.6K 0.48% 45
2025
Q4
$4.86M Buy
46,154
+302
+0.7% +$28.3K 0.41% 50
2025
Q3
$3.85M Buy
45,852
+2,196
+5% +$181K 0.33% 60
2025
Q2
$3.46M Buy
43,656
+1,313
+3% +$104K 0.32% 62
2025
Q1
$3.8M Buy
42,343
+2,354
+6% +$220K 0.36% 54
2024
Q4
$3.98M Buy
39,989
+112
+0.3% +$11.5K 0.37% 51
2024
Q3
$4.53M Buy
39,877
+1,045
+3% +$124K 0.43% 47
2024
Q2
$4.81M Buy
38,832
+70
+0.2% +$9.02K 0.5% 41
2024
Q1
$5.11M Sell
38,762
-907
-2% -$112K 0.55% 37
2023
Q4
$4.32M Sell
39,669
-411
-1% -$42.7K 0.51% 39
2023
Q3
$4.13M Sell
40,080
-500
-1% -$53.9K 0.54% 37
2023
Q2
$4.68M Sell
40,580
-520
-1% -$59K 0.62% 33
2023
Q1
$4.37M Sell
41,100
-1,237
-3% -$134K 0.6% 35
2022
Q4
$4.7M Sell
42,337
-344
-0.8% -$35.2K 0.65% 35
2022
Q3
$3.68M Buy
42,681
+123
+0.3% +$11K 0.57% 32
2022
Q2
$3.88M Buy
42,558
+490
+1% +$43.4K 0.55% 31
2022
Q1
$3.45M Buy
42,068
+2,976
+8% +$235K 0.47% 37
2021
Q4
$3M Buy
39,092
+631
+2% +$50.3K 0.37% 39
2021
Q3
$2.89M Buy
38,461
+798
+2% +$60.7K 0.38% 39
2021
Q2
$2.93M Buy
37,663
+47
+0.1% +$3.5K 0.38% 39
2021
Q1
$2.77M Buy
37,616
+1,027
+3% +$75.8K 0.38% 41
2020
Q4
$2.86M Buy
36,589
+414
+1% +$31.7K 0.43% 32
2020
Q3
$2.86M Sell
36,175
-1,576
-4% -$123K 0.46% 28
2020
Q2
$2.79M Sell
37,751
-1,147
-3% -$86.3K 0.49% 25
2020
Q1
$2.86M Sell
38,898
-446
-1% -$35.1K 0.61% 23
2019
Q4
$3.41M Buy
39,344
+144
+0.4% +$11.8K 0.58% 23
2019
Q3
$3.15M Sell
39,200
-1,000
-2% -$80.1K 0.58% 22
2019
Q2
$3.22M Sell
40,200
-1,029
-2% -$78.8K 0.62% 26
2019
Q1
$3.27M Sell
41,229
-1,118
-3% -$83.6K 0.77% 25
2018
Q4
$3.09M Sell
42,347
-2,787
-6% -$197K 0.99% 21
2018
Q3
$3.06M Sell
45,134
-1,990
-4% -$127K 0.77% 23
2018
Q2
$2.73M Buy
47,124
+9,475
+25% +$535K 0.71% 27
2018
Q1
$1.96M Buy
37,649
+1,440
+4% +$77.8K 0.51% 44
2017
Q4
$1.94M Buy
36,209
+1,443
+4% +$80K 0.51% 46
2017
Q3
$2.12M Buy
34,766
+513
+1% +$31.1K 0.56% 40
2017
Q2
$2.1M Buy
34,253
+1,894
+6% +$115K 0.59% 37
2017
Q1
$1.96M Buy
32,359
+891
+3% +$54.1K 0.54% 43
2016
Q4
$1.77M Buy
31,468
+930
+3% +$54.4K 0.54% 45
2016
Q3
$1.82M Sell
30,538
-276
-0.9% -$16.1K 0.58% 35
2016
Q2
$1.69M Buy
30,814
+17
+0.1% +$905 0.55% 42
2016
Q1
$1.55M Buy
30,797
+409
+1% +$20K 0.5% 47
2015
Q4
$1.53M Buy
30,388
+860
+3% +$43.4K 0.55% 45
2015
Q3
$1.39M Buy
29,528
+226
+0.8% +$12K 0.6% 43
2015
Q2
$1.59M Buy
29,302
+433
+1% +$24.3K 0.57% 41
2015
Q1
$1.58M Buy
28,869
+585
+2% +$33.1K 0.55% 43
2014
Q4
$1.53M Buy
+28,284
New +$1.58M 0.54% 42

Other funds holding MRK

Hengehold Capital Management's MRK Position: Q2 2026 in Review

Hengehold Capital Management increased its Merck (MRK) stake by 3.5% in Q2 2026, buying an estimated $186K and bringing the position to 47,453 shares worth $6.1M. The position accounts for 0.47% of the portfolio, ranked #45.

Hengehold Capital Management first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hengehold Capital Management held 47,453 shares of Merck worth $6.1M as of Q2 2026.
  • Hengehold Capital Management bought 1,590 Merck shares in Q2 2026, an estimated $186K.
  • Merck made up 0.47% of Hengehold Capital Management's portfolio in Q2 2026, its #45 holding.
  • Hengehold Capital Management first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.